These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 369031)

  • 1. Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue.
    Ashida S; Abiko Y
    Thromb Res; 1978 Nov; 13(5):901-8. PubMed ID: 369031
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of acetylsalicyclic and nicotinic acids and complamin on the formation of a prostacyclin-like substance by the aortic wall].
    Lakin KM; Baluda VP; Lukoianova TI; Romanovskaia VN; Baluda MV
    Farmakol Toksikol; 1980; 43(5):581-5. PubMed ID: 7004908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 5. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of ticlopidine and lysine acetylsalicylate in experimental atheromatosis. Effects on the production of PGI2].
    Lasierra J; Viladés E; Fernández A; Díez M; Gil M; Velázquez E
    Arch Farmacol Toxicol; 1985 Aug; 11(2):109-16. PubMed ID: 3936423
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin, thromboxane, and prostacyclin in rats: A dilemma resolved?
    Livio M; Villa S; de Gaetano G
    Lancet; 1978 Jun; 1(8077):1307. PubMed ID: 78064
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.
    Merino J; Livio M; Rajtar G; de Gaetano G
    Biochem Pharmacol; 1980 Apr; 29(8):1093-6. PubMed ID: 6770871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.
    Weksler BB; Marcus AJ; Jaffe EA
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3922-6. PubMed ID: 333448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells.
    Gordon JL; Pearson JD
    Br J Pharmacol; 1978 Dec; 64(4):481-3. PubMed ID: 365283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of aspirin on prostacyclin production (author's transl)].
    Maekawa T; Kobayashi N; Tanaka S; Arai H
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):551-2. PubMed ID: 386695
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)].
    Mikashima H; Goto K
    Yakugaku Zasshi; 1982 Jan; 102(1):99-103. PubMed ID: 7045328
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat.
    Randon J; Lefort J; Vargaftig BB
    Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related difference in the effect of aspirin on prostaglandin metabolism in rat platelet and aorta.
    Morikawa M; Inoue M; Kojima T; Uchiyama K; Tsuboi M
    Biochem Biophys Res Commun; 1981 Nov; 103(1):77-81. PubMed ID: 7032525
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Lancet; 1979 Dec; 2(8154):1213-7. PubMed ID: 92623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.